Cognizant Technology Solutions Corporation (CTSH)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 17 | 19 | 19 | 19 | 20 | 21 | 22 | 22 |
| Operating profit | $bn | 4 | 3 | ||||||
| Net profit | $bn | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| EPS reported | $ | 4.55 | 4.65 | ||||||
| Operating cashflow per share | $ | 5.99 | 6.26 | ||||||
| Capex per share | $ | 0.60 | 0.68 | ||||||
| FCF per share | $ | 5.40 | 5.58 | ||||||
| Free cash flow | $bn | 3 | 3 | ||||||
| Net debt | $bn | -1 | 1 | ||||||
| Book value equity | $bn | 15 | 14 | ||||||
| Book value per share | $ | 31.15 | 31.03 | ||||||
| Number of shares | m | 482 | 466 | ||||||
| DPS (TTM paid) | $ | 1.24 | 1.30 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 18.24 | 12.33 | ||||||
| P/B LTM | x | 2.66 | 2.76 | ||||||
| P/S LTM | x | 1.89 | 1.84 | ||||||
| P/FCF LTM | x | 15.38 | 15.37 | ||||||
| EV/EBITDA LTM | x | 9.49 | 9.99 | ||||||
| EV/Sales LTM | x | 1.88 | 1.35 | ||||||
| Earnings Yield LTM | % | +5.48% | +8.11% | ||||||
| FCF Yield | % | +6.50% | +6.51% | ||||||
| Quality | |||||||||
| ROE | % | +14.85% | +14.94% | ||||||
| ROIC | % | +12.31% | +12.32% | ||||||
| Operating margin | % | +16.72% | +15.76% | ||||||
| Gross margin | % | +33.72% | +32.00% | ||||||
| FCF/Sales | % | +12.29% | +12.00% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +0.89% | +3.10% | ||||||
| Sales Growth YoY | % | +6.95% | +9.66% | ||||||
| Net Income Growth YoY | % | -0.45% | -0.89% | ||||||
| FCF Growth | % | +42.04% | +42.20% | ||||||
| Operating Profit Growth | % | +22.03% | +17.91% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +1.53% | +2.09% | ||||||
| Dividend Growth | % | +3.33% | +8.33% | ||||||
| Payout Ratio | % | +27.81% | +27.80% | ||||||
| FCF/Debt | x | 1.65 | 1.24 | ||||||
| Net Debt/EBITDA | x | -0.08 | 0.27 | ||||||
| EBIT/Net interest | x | 95.38 | 94.72 | ||||||
| Net debt/market cap | % | +2.89% | +5.56% | ||||||
| Net debt/Equity | x | -0.05 | 0.04 | ||||||
| Gross debt/equity | x | 0.10 | 0.14 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Cognizant Technology Solutions Corporation (CTSH)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free